Dystrophin: The dead calm of a dogma

por Górecki, Dariusz C.
Publicado 2016

Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD

por Górecki, Dariusz C.
Publicado 2022

The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies

por Zabłocki, Krzysztof, Górecki, Dariusz C.
Publicado 2023

P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?

por Young, Chris N. J., Górecki, Dariusz C.
Publicado 2018

Disrupted Calcium Homeostasis in Duchenne Muscular Dystrophy: A Common Mechanism behind Diverse Consequences

por Zabłocka, Barbara, Górecki, Dariusz C., Zabłocki, Krzysztof
Publicado 2021

Primary mouse myoblast metabotropic purinoceptor profiles and calcium signalling differ with their muscle origin and are altered in mdx dystrophinopathy

por Róg, Justyna, Oksiejuk, Aleksandra, Górecki, Dariusz C., Zabłocki, Krzysztof
Publicado 2023

Protein-polymer nano-machines. Towards synthetic control of biological processes

por Pennadam, Sivanand S, Firman, Keith, Alexander, Cameron, Górecki, Dariusz C
Publicado 2004

Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?

por Zabłocka, Barbara, Goldspink, Paul H., Goldspink, Geoffrey, Górecki, Dariusz C.
Publicado 2012

Aberrant Location of Inhibitory Synaptic Marker Proteins in the Hippocampus of Dystrophin-Deficient Mice: Implications for Cognitive Impairment in Duchenne Muscular Dystrophy

por Krasowska, Elżbieta, Zabłocki, Krzysztof, Górecki, Dariusz C., Swinny, Jerome D.
Publicado 2014

Specific Dystrophins Selectively Associate with Inhibitory and Excitatory Synapses of the Mouse Cerebellum and their Loss Alters Expression of P2X7 Purinoceptors and Pro-Inflammato...

por Jackson, Torquil, Seifi, Mohsen, Górecki, Dariusz C., Swinny, Jerome D.
Publicado 2021

Butylglyceryl Pectin Nanoparticles: Synthesis, Formulation and Characterization

por Bostanudin, Mohammad F., Arafat, Mosab, Sarfraz, Muhammad, Górecki, Dariusz C., Barbu, Eugen
Publicado 2019

Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients

por Alnassar, Nancy, Borczyk, Malgorzata, Tsagkogeorga, Georgia, Korostynski, Michal, Han, Namshik, Górecki, Dariusz C.
Publicado 2023

α-Dystrobrevin knockout mice have increased motivation for appetitive reward and altered brain cannabinoid receptor 1 expression

por Hawkes, Cheryl A., Heath, Christopher J., Sharp, Matthew M., Górecki, Dariusz C., Carare, Roxana O.
Publicado 2022

A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90

por Young, Christopher NJ, Sinadinos, Anthony, Lefebvre, Alexis, Chan, Philippe, Arkle, Stephen, Vaudry, David, Gorecki, Dariusz C
Publicado 2015

P2X7 Purinoceptor Affects Ectopic Calcification of Dystrophic Muscles

por Rumney, Robin M. H., Róg, Justyna, Chira, Natalia, Kao, Alexander P., Al-Khalidi, Rasha, Górecki, Dariusz C.
Publicado 2022

P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment

por Young, Christopher N J, Brutkowski, Wojciech, Lien, Chun-Fu, Arkle, Stephen, Lochmüller, Hanns, Zabłocki, Krzysztof, Górecki, Dariusz C
Publicado 2012

Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts

por Gosselin, Maxime RF, Mournetas, Virginie, Borczyk, Malgorzata, Verma, Suraj, Occhipinti, Annalisa, Róg, Justyna, Bozycki, Lukasz, Korostynski, Michal, Robson, Samuel C, Angione, Claudio, Pinset, Christian, Gorecki, Dariusz C
Publicado 2022

The α-dystrobrevins play a key role in maintaining the structure and function of the extracellular matrix–significance for protein elimination failure arteriopathies

por Sharp, Matthew MacGregor, Cassidy, Jordan, Thornton, Thomas, Lyles, James, Keable, Abby, Gatherer, Maureen, Yasui, Masato, Abe, Yoichiro, Shibata, Shinsuke, Weller, Roy O., Górecki, Dariusz C., Carare, Roxana O.
Publicado 2021

Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset

por Mournetas, Virginie, Massouridès, Emmanuelle, Dupont, Jean‐Baptiste, Kornobis, Etienne, Polvèche, Hélène, Jarrige, Margot, Dorval, Alan R.L., Gosselin, Maxime R.F., Manousopoulou, Antigoni, Garbis, Spiros D., Górecki, Dariusz C., Pinset, Christian
Publicado 2021

Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism

por Al-Khalidi, Rasha, Panicucci, Chiara, Cox, Paul, Chira, Natalia, Róg, Justyna, Young, Christopher N. J., McGeehan, Rhiannon E., Ambati, Kameshwari, Ambati, Jayakrishna, Zabłocki, Krzysztof, Gazzerro, Elisabetta, Arkle, Stephen, Bruno, Claudio, Górecki, Dariusz C.
Publicado 2018